PA

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Maca SM et al. - IVTA might be considered as a treatment for patients with chronic CMO when persistent despite previous systemic steroid therapy. Even patients without sustained resolution of CMO after IVTA might benefit in terms of transiently increasing visual acuity, but progression of cataract and rise in intraocular pressure limit repeatability.

Related Articles

Tubulointerstitial nephritis and uveitis syndrome
Current Opinion in Ophthalmology, 10/27/09    Relevance Score: 89%

Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/02/09    Relevance Score: 89%

Cataract Surgery Under Infliximab Therapy in a Patient With Behcet's Disease
Journal of Ocular Pharmacology and Therapeutics, 10/30/09    Relevance Score: 87%

Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin
Eye, 10/26/09    Relevance Score: 87%

General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets, 10/09/09    Relevance Score: 87%

Today in Ophthalmology...keeping you current

Thyroid Eye Disease: Pathogenesis and Treatment
Ophthalmologica, 12/01/09

Chorioretinectomy for perforating or severe intraocular foreign body injuries
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/01/09

Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs heterochromic cyclitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/01/09